首页|溴结构域蛋白4及其抑制剂在炎症性疾病中的研究进展

溴结构域蛋白4及其抑制剂在炎症性疾病中的研究进展

扫码查看
溴结构域(bromodomain,BD)是一种高度保守的蛋白质结构域,具有特异性识别结合乙酰化赖氨酸残基的生物学功能。溴结构域蛋白4(bromodomain-containing protein 4,BRD4)是溴结构域和超末端结构(bromodomain and extra-terminal domain,BET)家族成员之一,因对基因转录具有强大的调控能力而受到较多关注。目前,靶向BRD4的小分子抑制剂在抗炎和抗癌领域展现出巨大的潜力。本文介绍了 BRD4的生物学功能和在人体组织中的表达分布,结合BRD4抑制剂的药物研发现状重点阐述BRD4抑制剂在炎症性疾病中的作用。
Research advances of BRD4 and its inhibitors in inflammatory diseases
The bromodomain(BD)is a highly conserved protein structural domain that has the biological function of specifically recognizing and binding acetylated lysine residues.The bromodomain-containing protein 4(BRD4)is a member of the bromodomain and extra-terminal domain(BET)family,which has received much attention for its powerful ability to regulate gene transcription.Currently,small molecule inhibitors targeting BRD4 have shown great potential in anti-inflamma-tory and anti-cancer fields.This paper described the biological function and distribution of BRD4 in human tissues,summa-rizes the current status of drug development of BRD4 inhibitors,and focuses on the role of BRD4 inhibitors in inflammatory diseases.

BRD4Inflammatory diseasesInhibitorMechanism study

熊政翰、尹力、胡庆华

展开 >

中国药科大学药学院,江苏南京 211198

溴结构域蛋白4 炎症性疾病 抑制剂 机制研究

江苏省自然科学基金面上项目

BK20211223

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(3)
  • 61